Market Summary
USD65.97-2.20
Market Closed-3.23%
IFF Stock Price
IFF RSI Chart
IFF Valuation
IFF Price/Sales (Trailing)
IFF Profitability
IFF Fundamentals
IFF Revenue
IFF Earnings
Price Action
52 Week Range
62.11118.34
(Low)(High)
Last 7 days
0.5%
Last 30 days
-2.3%
Last 90 days
-14.3%
Trailing 12 Months
-25.6%
IFF Financial Health
IFF Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for IFF
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-09-01 | Borg Deborah | sold (taxes) | -856,628 | 70.25 | -12,194 | evp, chief hr and d&i officer |
2023-09-01 | Borg Deborah | acquired | - | - | 27,614 | evp, chief hr and d&i officer |
2023-05-11 | Fauchon de Villeplee Christophe | sold | -170,282 | 86.35 | -1,972 | president, scent |
2023-05-04 | O'Byrne Kevin | acquired | - | - | 262 | - |
2023-05-04 | Bruno Barry A. | acquired | - | - | 1,245 | - |
2023-05-04 | Hu Gaoxiang | acquired | - | - | 434 | - |
2023-05-04 | Costa Mark J | acquired | - | - | 468 | - |
2023-05-04 | Gold Christina A | acquired | - | - | 1,245 | - |
2023-05-04 | Willoughby Dawn C | acquired | - | - | 434 | - |
2023-04-06 | Yep Gregory L | sold (taxes) | -67,032 | 91.45 | -733 | evp, chief scientific officer |
Which funds bought or sold IFF recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | added | 186 | 44,716,000 | 74,865,000 | 0.05% |
2023-09-14 | IMS Capital Management | sold off | -100 | -248,292 | - | -% |
2023-09-12 | Farther Finance Advisors, LLC | reduced | -41.2 | -9,755 | 10,108 | -% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | unchanged | - | -1,336 | 8,596 | -% |
2023-09-05 | Delos Wealth Advisors, LLC | unchanged | - | -49.00 | 319 | -% |
2023-09-01 | Portside Wealth Group, LLC | new | - | 736,211 | 736,211 | 0.14% |
2023-08-28 | BASSETT HARGROVE INVESTMENT COUNSEL, LLC | added | 0.15 | 90,000 | 708,000 | 1.33% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | -660,558 | 4,250,110 | 0.04% |
2023-08-23 | HEADINVEST, LLC | sold off | -100 | -361,403 | - | -% |
2023-08-23 | Stonebridge Capital Advisors LLC | unchanged | - | -631 | 4,059 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of International Flavors & Fragrances
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Jul 05, 2023 | winder investment pte ltd | 0% | 0 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 12.52% | 31,920,258 | SC 13G/A | |
| Feb 03, 2023 | blackrock inc. | 8.6% | 21,920,824 | SC 13G/A | |
| Feb 14, 2022 | alliancebernstein l.p. | 1.5% | 3,768,731 | SC 13G/A | |
| Feb 10, 2022 | vanguard group inc | 11.89% | 30,267,303 | SC 13G/A | |
| Feb 10, 2022 | winder investment pte ltd | 9.9% | 25,109,000 | SC 13G/A | |
| Feb 04, 2022 | winder investment pte ltd | 9.9% | 25,109,000 | SC 13D/A | |
| Feb 01, 2022 | blackrock inc. | 7.5% | 19,198,319 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 10.03% | 10,730,935 | SC 13G/A | |
| Feb 08, 2021 | alliancebernstein l.p. | 7.2% | 7,654,749 | SC 13G/A |
Recent SEC filings of International Flavors & Fragrances
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 19, 2023 | 8-K | Current Report | |
| Sep 06, 2023 | 4 | Insider Trading | |
| Aug 09, 2023 | 10-Q | Quarterly Report | |
| Aug 07, 2023 | 8-K | Current Report | |
| Jul 05, 2023 | SC 13G/A | Major Ownership Report | |
| Jul 05, 2023 | 4 | Insider Trading | |
| Jul 05, 2023 | 4 | Insider Trading | |
| Jun 28, 2023 | 11-K | Employee Benefit Details |
IFF Fair Value
Loading...
Peers (Alternatives to International Flavors & Fragrances)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
LYB | 30.7B | 43.0B | -4.27% | 28.32% | 14.54 | 0.71 | -19.65% | -61.23% |
IFF | 17.4B | 11.9B | -2.34% | -25.56% | -7.92 | 1.47 | -6.11% | -441.15% |
WLK | 15.9B | 13.9B | -6.40% | 46.70% | 11.9 | 1.15 | -8.20% | -53.46% |
RPM | 12.2B | 7.3B | -5.00% | 13.36% | 25.5 | 1.68 | 8.18% | -2.60% |
PPG | - | 17.9B | -8.62% | 16.92% | - | - | 1.96% | 21.57% |
| MID-CAP | ||||||||
AXTA | - | 5.1B | -5.48% | 26.23% | - | - | 9.03% | 9.70% |
OLN | 6.3B | 7.8B | -15.12% | 18.82% | 7.76 | 0.8 | -20.33% | -46.41% |
NEU | 4.4B | 2.8B | -3.00% | 53.10% | 12.43 | 1.58 | 7.02% | 79.95% |
SXT | 2.5B | 1.5B | -5.17% | -16.29% | 18.51 | 1.69 | 2.92% | -2.93% |
| SMALL-CAP | ||||||||
FF | 313.8M | 395.4M | -0.55% | 22.01% | 7.48 | 0.79 | 6.42% | 107.62% |
WLKP | - | 1.4B | -5.43% | -0.74% | - | - | -5.70% | -3.36% |
AMRS | 29.3M | 268.2M | -95.00% | -98.59% | -0.05 | 0.11 | 20.46% | -592.58% |
International Flavors & Fragrances News
Returns for IFF
Cumulative Returns on IFF
-0.1%
10-Year Cumulative Returns
-8.3%
7-Year Cumulative Returns
-11.7%
5-Year Cumulative Returns
-16.3%
3-Year Cumulative Returns
Risks for IFF
What is the probability of a big loss on IFF?
74.6%
Probability that International Flavors & Fragrances stock will be more than 20% underwater in next one year
27.7%
Probability that International Flavors & Fragrances stock will be more than 30% underwater in next one year.
10.4%
Probability that International Flavors & Fragrances stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does IFF drawdown profile look like?
Y-axis is the maximum loss one would have experienced if International Flavors & Fragrances was unfortunately bought at previous high price.
Drawdowns
Financials for International Flavors & Fragrances
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | -3.1% | 11,863 | 12,241 | 12,440 | 12,627 | 12,635 | 12,417 | 11,656 | 9,895 | 8,092 | 6,202 | 5,084 | 5,098 | 5,097 | 5,190 | 5,140 | 5,075 | 4,716 | 4,344 | 3,978 | 3,613 | 3,579 |
| Gross Profit | -5.1% | 3,767 | 3,970 | 4,151 | 4,263 | 4,352 | 4,126 | 3,735 | 3,268 | 2,702 | 2,274 | 2,086 | 2,074 | 2,084 | 2,148 | 2,113 | 2,088 | 1,956 | 1,808 | 1,683 | 1,561 | 1,541 |
| S&GA Expenses | -0.6% | 1,752 | 1,763 | 1,768 | 1,778 | 1,801 | 1,757 | 1,749 | 1,553 | 1,352 | 1,170 | 949 | 937 | 913 | 893 | 876 | 884 | 831 | 778 | 707 | 599 | 587 |
| R&D Expenses | 0.5% | 610 | 607 | 603 | 626 | 637 | 643 | 629 | 564 | 497 | 414 | 357 | 342 | 338 | 341 | 346 | 344 | 334 | 324 | 312 | 305 | 304 |
| EBITDA | 100.0% | - | -369 | -110 | -9.00 | 2,271 | 2,206 | 1,799 | 1,510 | 1,112 | 884 | 898 | 924 | 971 | 1,032 | 1,019 | - | - | - | - | - | - |
| EBITDA Margin | 100.0% | - | -0.03* | -0.01* | 0.00* | 0.54* | 0.18* | 0.15* | 0.15* | 0.14* | 0.14* | 0.18* | 0.18* | 0.19* | 0.20* | 0.20* | - | - | - | - | - | - |
| Interest Expenses | 10.4% | 414 | 375 | 336 | 305 | 296 | 296 | 289 | 249 | 210 | 165 | 132 | 134 | 133 | 133 | 138 | 141 | 132 | 153 | 133 | 110 | 105 |
| Earnings Before Taxes | -4.2% | -1,976 | -1,896 | -1,625 | -1,506 | 779 | 693 | 354 | 319 | 174 | 234 | 441 | 458 | 510 | 575 | 557 | 527 | 471 | 423 | 448 | 497 | 537 |
| EBT Margin | 100.0% | - | -0.15* | -0.13* | -0.12* | 0.19* | 0.06* | 0.03* | 0.03* | 0.02* | 0.04* | 0.09* | 0.09* | 0.10* | 0.11* | 0.11* | - | - | - | - | - | - |
| Net Income | -3.8% | -2,197 | -2,117 | -1,864 | -1,747 | 644 | 565 | 279 | 251 | 142 | 201 | 367 | 384 | 426 | 475 | 460 | 388 | 356 | 319 | 340 | 284 | 299 |
| Net Income Margin | 100.0% | - | -0.17* | -0.15* | -0.14* | 0.15* | 0.05* | 0.02* | 0.03* | 0.02* | 0.03* | 0.07* | 0.08* | 0.08* | 0.09* | 0.09* | - | - | - | - | - | - |
| Free Cashflow | 100.0% | - | -19.00 | -107 | 5.00 | 175 | 643 | 1,044 | 1,115 | 927 | 819 | 522 | 531 | 525 | 441 | 463 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
| Assets | -1.4% | 34,459 | 34,965 | 35,470 | 35,504 | 34,537 | 39,304 | 39,747 | 39,658 | 40,252 | 40,864 | 40,817 | 13,555 | 13,085 | 12,989 | 12,689 | 13,287 | 12,985 | 13,348 | 13,211 | 12,889 | 9,616 |
| Current Assets | - | 6,436 | - | 7,442 | 7,432 | 6,494 | 7,730 | 7,507 | 6,987 | 7,132 | 6,297 | 6,174 | 3,060 | 2,946 | 3,013 | 2,818 | 2,943 | 2,899 | 2,990 | 2,926 | 2,942 | 6,947 |
| Cash Equivalents | 4153.3% | 638 | 15.00 | 590 | 483 | 538 | 569 | 657 | 711 | 672 | 935 | 872 | 650 | 470 | 498 | 433 | 624 | 495 | 427 | 484 | 649 | 5,274 |
| Inventory | 2305.2% | 2,790 | 116 | 2,946 | 3,151 | 3,122 | 2,993 | 2,795 | 2,516 | 2,401 | 2,464 | 2,589 | 1,132 | 1,151 | 1,166 | 1,076 | 1,123 | 1,126 | 1,164 | 1,114 | 1,079 | 720 |
| Net PPE | 5377.9% | 4,218 | 77.00 | 4,224 | 4,203 | 4,055 | 4,177 | 4,295 | 4,368 | 4,295 | 4,566 | 4,587 | 1,458 | 1,380 | 1,356 | 1,339 | 1,387 | 1,314 | 1,316 | 1,294 | 1,241 | 875 |
| Goodwill | 4158.0% | 13,498 | 317 | 13,458 | 13,355 | 13,305 | 16,071 | 45.00 | 16,414 | 16,590 | 17,250 | 11,762 | 5,593 | 5,427 | 5,349 | 15.00 | 5,497 | 4,274 | 5,506 | 5,434 | 5,378 | 4,243 |
| Current Liabilities | - | 3,932 | - | 4,874 | 3,728 | 3,626 | 4,720 | 4,032 | 3,633 | 3,579 | 3,227 | 3,261 | 1,904 | 1,616 | 1,344 | 1,427 | 1,552 | 1,412 | 1,150 | 1,144 | 1,128 | 758 |
| LT Debt, Non Current | - | 9,208 | - | 9,220 | 10,373 | 10,260 | 10,363 | 10,738 | 10,768 | 10,818 | 11,354 | 11,330 | 3,779 | 3,891 | 4,182 | 3,947 | 3,997 | 4,008 | 4,429 | 4,421 | 4,504 | 4,331 |
| Shareholder's Equity | 42882.9% | 17,623 | 41.00 | 17,761 | 17,655 | 16,887 | 20,293 | 20,965 | 21,117 | 21,473 | 21,800 | 21,681 | 6,322 | 6,090 | 6,001 | 5,841 | 6,229 | 6,067 | 6,210 | 6,154 | 6,043 | 4,038 |
| Retained Earnings | - | 560 | - | 739 | 955 | 1,186 | 3,589 | 3,683 | 3,641 | 3,752 | 3,759 | 3,922 | 4,156 | 4,171 | 4,168 | 4,162 | 4,118 | 4,114 | 4,069 | 4,011 | 3,956 | 4,021 |
| Additional Paid-In Capital | - | 19,851 | - | 19,844 | 19,841 | 19,832 | 19,826 | 19,823 | 19,826 | 19,817 | 19,800 | 19,796 | 3,853 | 3,848 | 3,838 | 3,835 | 3,823 | 3,816 | 3,806 | 3,803 | 3,794 | 2,442 |
| Accumulated Depreciation | - | 2,186 | - | 2,085 | 1,977 | 1,978 | 1,961 | 1,889 | 1,793 | 1,608 | 1,582 | 1,501 | 1,470 | 1,409 | 1,342 | 1,293 | 1,304 | 1,303 | 1,315 | 1,287 | 1,252 | 1,250 |
| Shares Outstanding | - | 255 | - | 255 | 255 | 255 | 255 | 255 | 255 | 254 | 254 | 206 | 107 | 112 | 112 | 112 | 107 | 112 | 112 | 112 | 107 | 81.00 |
| Minority Interest | - | 32.00 | - | 32.00 | 30.00 | 34.00 | 33.00 | 32.00 | 35.00 | 47.00 | 39.00 | 39.00 | 12.00 | 12.00 | 13.00 | 13.00 | 12.00 | 11.00 | 11.00 | 11.00 | 10.00 | 6.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | 55.9% | 823 | 528 | 397 | 500 | 688 | 1,075 | 1,437 | 1,425 | 1,204 | 1,055 | 714 | 731 | 722 | 669 | 699 | 619 | 567 | 496 | 438 | 393 | 388 |
| Share Based Compensation | 7.7% | 56.00 | 52.00 | 49.00 | 47.00 | 52.00 | 52.00 | 54.00 | 53.00 | 44.00 | 38.00 | 36.00 | 35.00 | 35.00 | 35.00 | 34.00 | 34.00 | 33.00 | 29.00 | 29.00 | 28.00 | 29.00 |
| Cashflow From Investing | 135.1% | 1,643 | 699 | 745 | 794 | -394 | -254 | -18.00 | 7.00 | -80.00 | -29.00 | -187 | -187 | -156 | -178 | -226 | -5,068 | -5,090 | -5,068 | -5,013 | -139 | -137 |
| Cashflow From Financing | -98.4% | -2,472 | -1,246 | -1,229 | -1,369 | -500 | -994 | -1,304 | -1,116 | -724 | -620 | -512 | -557 | -485 | -499 | -505 | -316 | 4,661 | 4,773 | 4,871 | 4,721 | -410 |
| Dividend Payments | 0.7% | 821 | 815 | 810 | 805 | 795 | 786 | 667 | 549 | 437 | 325 | 323 | 321 | 318 | 316 | 314 | 300 | 277 | 254 | 230 | 218 | 214 |
| Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.00 | 15.00 | 20.00 | 20.00 |
IFF Income Statement
2023-06-30CONSOLIDATED STATEMENT OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Net sales | $ 2,929 | $ 3,307 | $ 5,956 | $ 6,533 |
| Cost of goods sold | 1,996 | 2,171 | 4,059 | 4,252 |
| Gross profit | 933 | 1,136 | 1,897 | 2,281 |
| Research and development expenses | 161 | 158 | 322 | 315 |
| Selling and administrative expenses | 445 | 456 | 899 | 915 |
| Amortization of acquisition-related intangibles | 172 | 184 | 343 | 370 |
| Impairment of long-lived assets | 0 | 120 | 0 | 120 |
| Restructuring and other charges | 7 | 7 | 59 | 9 |
| Gain (Loss) on Disposition of Assets | (3) | 2 | 2 | 2 |
| Operating profit | 145 | 213 | 276 | 554 |
| Interest expense | 116 | 77 | 227 | 149 |
| Other (income) expense, net | (21) | 6 | (15) | (10) |
| Income before taxes | 50 | 130 | 64 | 415 |
| Provision for income taxes | 23 | 21 | 45 | 60 |
| Net income | 27 | 109 | 19 | 355 |
| Net income attributable to non-controlling interests | 0 | 2 | 1 | 4 |
| Net income attributable to IFF shareholders | $ 27 | $ 107 | $ 18 | $ 351 |
| Net income per share - basic (in dollars per share) | $ 0.11 | $ 0.43 | $ 0.07 | $ 1.38 |
| Net income per share - diluted (in dollars per share) | $ 0.11 | $ 0.43 | $ 0.07 | $ 1.38 |
| Average number of shares outstanding - basic (in shares) | 255 | 255 | 255 | 255 |
| Average number of shares outstanding - diluted (in shares) | 255 | 255 | 255 | 255 |
| Dividends declared per share, in dollars per share | $ 0.81 | $ 0.79 | $ 1.62 | $ 1.58 |
| Other comprehensive income (loss), after tax: | ||||
| Foreign currency translation adjustments | $ 60 | $ (589) | $ 344 | $ (788) |
| Pension and postretirement liability adjustment | (1) | 1 | (3) | 1 |
| Net current period other comprehensive income (loss) | 59 | (588) | 341 | (787) |
| Comprehensive income (loss) | 86 | (479) | 360 | (432) |
| Comprehensive income (loss) attributable to IFF shareholders | $ 86 | $ (481) | $ 359 | $ (436) |
IFF Balance Sheet
2023-06-30CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current Assets: | ||
| Cash and cash equivalents | $ 638 | $ 483 |
| Restricted cash | 11 | 10 |
| Trade receivables | 1,887 | 1,818 |
| Inventories: | ||
| Raw materials | 919 | 1,073 |
| Work in process | 474 | 442 |
| Finished goods | 1,397 | 1,636 |
| Total Inventories | 2,790 | 3,151 |
| Assets held for sale | 212 | 1,200 |
| Prepaid expenses and other current assets | 898 | 770 |
| Total Current Assets | 6,436 | 7,432 |
| Property, plant and equipment, at cost | 6,404 | 6,180 |
| Accumulated depreciation | (2,186) | (1,977) |
| Total Property Plant and Equipment | 4,218 | 4,203 |
| Goodwill | 13,498 | 13,355 |
| Other intangible assets, net | 8,813 | 9,082 |
| Operating lease right-of-use assets | 740 | 743 |
| Other assets | 754 | 689 |
| Total Assets | 34,459 | 35,504 |
| Current Liabilities: | ||
| Bank borrowings, overdrafts, and current portion of long-term debt | 1,203 | 410 |
| Commercial paper | 159 | 187 |
| Accounts payable | 1,227 | 1,418 |
| Accrued payroll and bonus | 205 | 267 |
| Dividends payable | 206 | 206 |
| Liabilities held for sale | 13 | 212 |
| Other current liabilities | 919 | 1,028 |
| Total Current Liabilities | 3,932 | 3,728 |
| Long-term debt | 9,208 | 10,373 |
| Retirement liabilities | 233 | 231 |
| Deferred income taxes | 2,183 | 2,265 |
| Operating lease liability | 683 | 672 |
| Other liabilities | 504 | 491 |
| Total Other Liabilities | 12,811 | 14,032 |
| Commitments and Contingencies | ||
| Redeemable non-controlling interests | 61 | 59 |
| Shareholders' Equity: | ||
| Common Stock, Value, Issued | 35 | 35 |
| Capital in excess of par value | 19,851 | 19,841 |
| Retained earnings | 560 | 955 |
| Accumulated other comprehensive loss | (1,857) | (2,198) |
| Treasury Stock, Value | (966) | (978) |
| Total Shareholders’ Equity | 17,623 | 17,655 |
| Non-controlling interest | 32 | 30 |
| Total Shareholders’ Equity including Non-controlling interest | 17,655 | 17,685 |
| Total Liabilities and Shareholders’ Equity | $ 34,459 | $ 35,504 |
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.